AstraZeneca PLC is 146.0x more valuable than Mineralys Therapeutics, Inc. by market capitalization ($286.27 B vs $1.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MLYS | AZN |
|---|---|---|
| Market cap | $1.96 B | $286.27 B |
| US-listed rank | #2113 | #45 |
| Net income (latest FY) | -$154.65M | - |
| SEC filings | 350 | 1,004 |
AstraZeneca PLC is 146.0x more valuable than Mineralys Therapeutics, Inc. by market capitalization ($286.27 B vs $1.96 B).
Full pages: Mineralys Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.